Name : DIRC2 Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN4134234626
| Long name | DIRC2 Primary Polyclonal Antibody |
| Also known as | DIRC2 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | DIRC2 |
| Specificity | This is a highly specific antibody against DIRC2 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human DIRC2 |
| Gene ID number | 84925 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | DIRC2 (disrupted in renal carcinoma protein 2) is a 478 amino acid multi-pass membrane protein that is primarily expressed in kidney proximal tubular cells, Fusion transcripts that result from these translocations may affect normal protein function, The genes encoding DIRC2 and DIRC3 are located at a translocation breakpoint which occurs frequently in individuals affected by familial renal cell carcinoma, There are two isoforms of DIRC2 which are produced as a result of alternative splicing events, This evidence suggests that, deregulation of the DIRC2 gene may cause haploinsufficiency and therefore result in the onset of tumor growth, due to its chromosomal location, Belonging to the major facilitator superfamily |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | DIRC 2, DIRC2_HUMAN, Disrupted in renal cancer protein 2, Disrupted in renal carcinoma 2, FLJ14784, NP_116228, RCC 4, RCC4, Renal cell carcinoma 4, Disrupted in renal carcinoma protein 2 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | DIRC2 |
| Short name | DIRC2 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | DIRC2 (Antibody to) |
| Alternative technique | antibodies |
| Identity | 16628 |
| Gene | DIRC2 |
| Long gene name | disrupted in renal carcinoma 2 |
| Synonyms | FLJ14784 RCC4 |
| Synonyms name | renal cell carcinoma 4 disrupted in renal cancer protein 2 |
| Locus | 3q21, 1 |
| Discovery year | 2002-03-19 |
| GenBank acession | AK027690 |
| Entrez gene record | 84925 |
| Pubmed identfication | 11912179 |
| RefSeq identity | NM_032839 |
| Classification | Solute carriers |
| Havana BLAST/BLAT | OTTHUMG00000159553 |